Cancerappy participated in the II international congress organized by ATG Symbio Spain that was held in
Barcelona at the Biomedical Research Park (PRBB) on July 1 and 2, 2023.
Our CEO had the opportunity to present our company and show our latest advances in the NMEs that we are developing.
Our CEO will be attending the BIO International in Boston from June 5th to 8th.
Cancerappy is dedicated to the discovery and development of new AI-based pharmaceuticals. Currently, we have a strong pipeline that validates and demonstrates our value proposition.
If you want to learn more about Cancerappy, feel free to find us at booth 7 in the Spain Pavilion.
More about Bio Convention:
https://www.bio.org/events/bio-international-convention
From 15th to 18th of May, our CEO and CMO will be attending various international events in Hong Kong introducing the latest advances of our company. They will attend Asia Summit on Global Health, Invest in Honk Kong #investHK, and different meeting with local business Angels.
Our CEO Luis Martín Ezama will be attending the #Meet2win23 event 11th and 12th of May, exposing the characteristics of our pipeline of new cancer drugs. We are developing first-in-class antibodies and small molecules against solid tumors.
April 20th. We are going to attend the 19th Annual Anglonordic Life Science Conference.
Meet us to discuss face to face about our latest works: CA04 first-in-class monoclonal antibody, CA05 first-in-class kinase inhibitor and CA07 novel PROTAC.
We can’t wait to hear from you.